Search research articles
Contact Us
Filters
Showing results (631-640 of 662) with videos related to
Page
of 67
Sort By:
The Journal of Biological Chemistry
|
July 28, 2010
Circular permutation provides an evolutionary link between two families of calcium-dependent carbohydrate binding modules
Cedric Montanier, James E Flint, David N Bolam, et al.
Pathogens (Basel, Switzerland)
|
October 25, 2024
Investigating Anthrax-Associated Virulence Genes among Archival and Contemporary <i>Bacillus cereus</i> Group Genomes
Susanna J Sabin, Cari A Beesley, Chung K Marston, et al.
JAMA Neurology
|
August 8, 2013
Therapeutic decisions in multiple sclerosis: moving beyond efficacy
Wolfgang Brück, Raff Gold, Brett T Lund, et al.
Journal of Neuroinflammation
|
June 17, 2020
Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis
Wendy Gilmore, Brett T Lund, Peili Li, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 11, 2003
Glatiramer acetate (Copaxone): comparison of continuous versus delayed therapy in a six-year organized multiple sclerosis trial
K P Johnson, B R Brooks, C C Ford, et al.
New Biotechnology
|
April 19, 2025
Site-directed antibodies targeting driver mutations of the KRAS protein
Xiaofeng Li, Qiana Mendez, Cassandra Chapados, et al.
Journal of Infection and Public Health
|
August 31, 2025
Melioidosis presenting as septic arthritis in hip joint of a 60-year old patient: Findings from a hospital-based surveillance in Bangladesh
Ayesha Jamal Ananna, Lovely Barai, Jamal Uddin Ahmed, et al.
Neurology
|
April 1, 1998
Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Copolymer 1 Multiple Sclerosis Study Group
K P Johnson, B R Brooks, J A Cohen, et al.
Eclinicalmedicine
|
July 26, 2021
Higher dose docosahexaenoic acid supplementation during pregnancy and early preterm birth: A randomised, double-blind, adaptive-design superiority trial
Susan E Carlson, Byron J Gajewski, Christina J Valentine, et al.
Frontiers in Immunology
|
September 7, 2023
Use of Epivolve phage display to generate a monoclonal antibody with opsonic activity directed against a subdominant epitope on extracellular loop 4 of <i>Treponema pallidum</i> BamA (TP0326)
Mary R Ferguson, Kristina N Delgado, Shannon McBride, et al.
Page
of 67
Search research articles
Search
Showing results (631-640 of 662) with videos related to
Sort By:
Page
of 67
The Journal of Biological Chemistry
|
July 28, 2010
Circular permutation provides an evolutionary link between two families of calcium-dependent carbohydrate binding modules
Cedric Montanier, James E Flint, David N Bolam, et al.
Pathogens (Basel, Switzerland)
|
October 25, 2024
Investigating Anthrax-Associated Virulence Genes among Archival and Contemporary <i>Bacillus cereus</i> Group Genomes
Susanna J Sabin, Cari A Beesley, Chung K Marston, et al.
JAMA Neurology
|
August 8, 2013
Therapeutic decisions in multiple sclerosis: moving beyond efficacy
Wolfgang Brück, Raff Gold, Brett T Lund, et al.
Journal of Neuroinflammation
|
June 17, 2020
Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis
Wendy Gilmore, Brett T Lund, Peili Li, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 11, 2003
Glatiramer acetate (Copaxone): comparison of continuous versus delayed therapy in a six-year organized multiple sclerosis trial
K P Johnson, B R Brooks, C C Ford, et al.
New Biotechnology
|
April 19, 2025
Site-directed antibodies targeting driver mutations of the KRAS protein
Xiaofeng Li, Qiana Mendez, Cassandra Chapados, et al.
Journal of Infection and Public Health
|
August 31, 2025
Melioidosis presenting as septic arthritis in hip joint of a 60-year old patient: Findings from a hospital-based surveillance in Bangladesh
Ayesha Jamal Ananna, Lovely Barai, Jamal Uddin Ahmed, et al.
Neurology
|
April 1, 1998
Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Copolymer 1 Multiple Sclerosis Study Group
K P Johnson, B R Brooks, J A Cohen, et al.
Eclinicalmedicine
|
July 26, 2021
Higher dose docosahexaenoic acid supplementation during pregnancy and early preterm birth: A randomised, double-blind, adaptive-design superiority trial
Susan E Carlson, Byron J Gajewski, Christina J Valentine, et al.
Frontiers in Immunology
|
September 7, 2023
Use of Epivolve phage display to generate a monoclonal antibody with opsonic activity directed against a subdominant epitope on extracellular loop 4 of <i>Treponema pallidum</i> BamA (TP0326)
Mary R Ferguson, Kristina N Delgado, Shannon McBride, et al.
Page
of 67